June 16, 2014 | By Emily Wasserman
Medtronic ($MDT) and Covidien ($COV) are riding high on their recently announced $42.9 billion merger–a deal that will pay dividends further down the line and expand the companies’ hospital access, top-level management said in a conference call on Monday morning. Management highlighted Covidien’s surgical division in particular, its largest and fastest growing group.
Medtronic CEO Omar Ishrak, CFO Gary L. Ellis and Covidien CEO José E. Almeida sat down this morning to flesh out the purchase, one that allows the company to combine their offerings and sets the stage for greater success in the future, the companies said during the call.
“Our collective portfolio for open and minimally invasive procedures will give us a broad platform over a wide range of surgical specialties,” Ishrak said. “We believe Medtronic’s deep expertise will accelerate introduction and rapid adoption in markets around the world.”
Read more: Medtronic gains better hospital access with Covidien purchase – FierceMedicalDevices http://www.fiercemedicaldevices.com/story/medtronic-gains-better-hospital-access-covidien-purchase/2014-06-16#ixzz34pxIGfoT
Subscribe at FierceMedicalDevices
